Correlation Between Pfizer and Sparx Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Sparx Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Sparx Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc CDR and Sparx Technology, you can compare the effects of market volatilities on Pfizer and Sparx Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Sparx Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Sparx Technology.

Diversification Opportunities for Pfizer and Sparx Technology

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and Sparx is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc CDR and Sparx Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sparx Technology and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc CDR are associated (or correlated) with Sparx Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sparx Technology has no effect on the direction of Pfizer i.e., Pfizer and Sparx Technology go up and down completely randomly.

Pair Corralation between Pfizer and Sparx Technology

Assuming the 90 days trading horizon Pfizer Inc CDR is expected to under-perform the Sparx Technology. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc CDR is 31.54 times less risky than Sparx Technology. The stock trades about -0.08 of its potential returns per unit of risk. The Sparx Technology is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  3.50  in Sparx Technology on September 5, 2024 and sell it today you would earn a total of  2,662  from holding Sparx Technology or generate 76071.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.8%
ValuesDaily Returns

Pfizer Inc CDR  vs.  Sparx Technology

 Performance 
       Timeline  
Pfizer Inc CDR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Sparx Technology 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Sparx Technology are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Sparx Technology showed solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and Sparx Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Sparx Technology

The main advantage of trading using opposite Pfizer and Sparx Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Sparx Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sparx Technology will offset losses from the drop in Sparx Technology's long position.
The idea behind Pfizer Inc CDR and Sparx Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA